PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT)

CUSIP: 74638P307

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 5 signals
Share change
+73,699
SEC-reported price per share
$4.04
Number of holders
14
Value change
+$297,739
Number of buys
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,895,142,857

Security key

74638P307

Report period

Q1 2026

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of PPBT - PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 10% 13D/G row: INTRACOASTAL CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
INTRACOASTAL CAPITAL, LLC 10%
Lincoln Alternative Strategies LLC 9.9%
SUSQUEHANNA SECURITIES, LLC 5.2%
Orca Capital AG 4.9%
Gil Efron 0.56%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
10%
$124,305,955
282,513,535 shares
+$36,106,330 31 Mar 2026
Lincoln Alternative Strategies LLC
13D/G
9.9%
$1,288,650
605,000 shares
$0 04 Sep 2025
SUSQUEHANNA SECURITIES, LLC
13D/G
5.2%
$63,888,312
93,953,400 shares
$0 31 Dec 2025
Orca Capital AG
13D/G
4.9%
$652,619
306,394 shares
$0 04 Sep 2025
Gil Efron
3/4/5
Chief Executive Officer
0.56%
$10,355,625
15,750,000 shares
18 Mar 2026
Michael Schickler
3/4/5
Head of Clinical & Reg Affairs
0.33%
$6,084,815
9,254,472 shares
18 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
75,656
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
14
Q1 2026 holders
14
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .